Finance

Lists
LKFT34:BVMF
Lakefront Biotherapeutics Nv Bdr
R$7.45
-0.40%
(-0.030) 1D
Oct 13, 10:11:23 AM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for LKFT34...
Open
R$7.45
High
R$7.45
Low
R$7.45
Mkt. cap
1.73B
Avg. vol.
141.00
Volume
1.00
52-wk high
R$8.08
52-wk low
R$5.97
Shares outstanding
65.90M
No. of employees
196
Open
R$7.45
High
R$7.45
Low
R$7.45
Mkt. cap
1.73B
Avg. vol.
141.00
Volume
1.00
52-wk high
R$8.08
52-wk low
R$5.97
Shares outstanding
65.90M
No. of employees
196
News stories
From web sources and news partners
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics Nv Bdr
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Last report
Aug 11, 2026
Fiscal period
Q2 2026
€0.03 / -€11.50
+100.26%beat
Revenue / Est. (EUR)
12.11M / 6.13M
+97.55%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-284.02%
86.83%
223.61%
17.42%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps